Patient Monitoring Market

Executive Summary

Patient Monitoring Market was valued at US $39.75 billion in 2021 and is projected to grow at 8.90% CAGR over the forecast period to reach US $66.30 billion by 2027. Patient Monitoring Market represented US $6.23 billion opportunity over 2019-2021 and estimated to create US $26.55 billion opportunity in 2027 over 2021.

Patient Monitoring from Consainsights analyses the Patient Monitoring Market in the Life Sciences industry over the forecast period to 2027.

Patient Monitoring research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Patient Monitoring segmentation includes Type of Device, Application, End User and Geography.

Based on the Type of Device, the Patient Monitoring analysis covers Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Multi-parameter Monitors, Respiratory Monitoring Devices, Other Types of Devices.

In Type of Device segment, Hemodynamic Monitoring Devices segment has highest cagr growth of 7.87%.

Based on the Application, the Patient Monitoring analysis covers Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, Other Applications.

In Application segment, Cardiology segment has highest cagr growth of 7.87%.

Based on the End User, the Patient Monitoring analysis covers Home Healthcare, Hospitals and Clinics, Other End Users.

In End User segment, Home Healthcare segment has highest cagr growth of 7.87%.

Based on the region, the Patient Monitoring analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), Johnson & Johnson, Masimo Corporation, Medtronic plc, Omron Corporation, Koninklijke Philips NV, Drägerwerk AG & Co. KGaA and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type of Device

Introduction

In 2021, Hemodynamic Monitoring Devices segment has the highest revenue of US $16.94 billion and is expected to grow at CAGR of 7.87% by 2027 Hemodynamic Monitoring Devices segment has highest cagr growth of 7.87%.

Hemodynamic Monitoring Devices

Hemodynamic Monitoring Devices segment was valued at US $14.28 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $28.25 billion by 2027. Hemodynamic Monitoring Devices segment represented US $2.66 billion opportunity over 2019-2021 and estimated to create US $11.31 billion opportunity in 2027 over 2021.

Neuromonitoring Devices

Neuromonitoring Devices segment was valued at US $8.93 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $17.66 billion by 2027. Neuromonitoring Devices segment represented US $1.66 billion opportunity over 2019-2021 and estimated to create US $7.07 billion opportunity in 2027 over 2021.

Cardiac Monitoring Devices

Cardiac Monitoring Devices segment was valued at US $5.10 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $10.09 billion by 2027. Cardiac Monitoring Devices segment represented US $0.95 billion opportunity over 2019-2021 and estimated to create US $4.04 billion opportunity in 2027 over 2021.

Multi-parameter Monitors

Multi-parameter Monitors segment was valued at US $3.39 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $6.71 billion by 2027. Multi-parameter Monitors segment represented US $0.63 billion opportunity over 2019-2021 and estimated to create US $2.69 billion opportunity in 2027 over 2021.

Respiratory Monitoring Devices

Respiratory Monitoring Devices segment was valued at US $1.27 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $2.51 billion by 2027. Respiratory Monitoring Devices segment represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $1.01 billion opportunity in 2027 over 2021.

Other Types of Devices

Other Types of Devices segment was valued at US $0.54 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $1.08 billion by 2027. Other Types of Devices segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.43 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiology segment has the highest revenue of US $16.97 billion and is expected to grow at CAGR of 7.87% by 2027 Cardiology segment has highest cagr growth of 7.87%.

Cardiology

Cardiology segment was valued at US $14.31 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $28.31 billion by 2027. Cardiology segment represented US $2.66 billion opportunity over 2019-2021 and estimated to create US $11.34 billion opportunity in 2027 over 2021.

Neurology

Neurology segment was valued at US $9.01 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $17.82 billion by 2027. Neurology segment represented US $1.68 billion opportunity over 2019-2021 and estimated to create US $7.14 billion opportunity in 2027 over 2021.

Respiratory

Respiratory segment was valued at US $4.18 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $8.27 billion by 2027. Respiratory segment represented US $0.78 billion opportunity over 2019-2021 and estimated to create US $3.31 billion opportunity in 2027 over 2021.

Fetal and Neonatal

Fetal and Neonatal segment was valued at US $3.04 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $6.01 billion by 2027. Fetal and Neonatal segment represented US $0.57 billion opportunity over 2019-2021 and estimated to create US $2.41 billion opportunity in 2027 over 2021.

Weight Management and Fitness Monitoring

Weight Management and Fitness Monitoring segment was valued at US $2.06 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $4.08 billion by 2027. Weight Management and Fitness Monitoring segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $1.63 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.92 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $1.81 billion by 2027. Other Applications segment represented US $0.17 billion opportunity over 2019-2021 and estimated to create US $0.73 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Home Healthcare segment has the highest revenue of US $19.78 billion and is expected to grow at CAGR of 7.87% by 2027 Home Healthcare segment has highest cagr growth of 7.87%.

Home Healthcare

Home Healthcare segment was valued at US $16.68 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $33.00 billion by 2027. Home Healthcare segment represented US $3.10 billion opportunity over 2019-2021 and estimated to create US $13.22 billion opportunity in 2027 over 2021.

Hospitals and Clinics

Hospitals and Clinics segment was valued at US $16.21 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $32.07 billion by 2027. Hospitals and Clinics segment represented US $3.01 billion opportunity over 2019-2021 and estimated to create US $12.84 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.62 billion in 2019 and is projected to grow at 7.87% CAGR over the forecast period to reach US $1.23 billion by 2027. Other End Users segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.49 billion opportunity in 2027 over 2021.